<?xml version="1.0"?>
<Articles JournalTitle="The Research in Heart Yield and Translational Medicine (RHYTHM)">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>20</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2025</Year>
        <Month>12</Month>
        <Day>06</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Acute Coronary Syndrome with Non-ST-Elevation Myocardial Infarction and Refractory Unstable Ventricular Tachycardia Complicated by Severe Acute Kidney and Liver Injury in Myxedema Crisis: A Case Report</title>
    <FirstPage>323</FirstPage>
    <LastPage>328</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Surya</FirstName>
        <LastName>Marthias</LastName>
        <affiliation locale="en_US">Universitas Batam</affiliation>
      </Author>
      <Author>
        <FirstName>Carla</FirstName>
        <LastName>Octavani</LastName>
        <affiliation locale="en_US">Faculty of Medicine Universitas Batam/Hj.Bunda Halimah Hospital, Batam Indonesia</affiliation>
      </Author>
      <Author>
        <FirstName>Mega</FirstName>
        <LastName>Hutapea</LastName>
        <affiliation locale="en_US">Faculty of Medicine Universitas Batam/Hj.Bunda Halimah Hospital, Batam Indonesia</affiliation>
      </Author>
      <Author>
        <FirstName>Ibrahim</FirstName>
        <LastName>Ibrahim</LastName>
        <affiliation locale="en_US">Faculty of Medicine Universitas Batam/Hj.Bunda Halimah Hospital, Batam Indonesia</affiliation>
      </Author>
      <Author>
        <FirstName>Nurjanah</FirstName>
        <LastName>Nurjanah</LastName>
        <affiliation locale="en_US">Faculty of Medicine Universitas Syiah Kuala, Aceh, Indonesia</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>06</Month>
        <Day>12</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>08</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Myxedema crisis, which occurs due to hypothyroidism, is a rare and life-threatening condition that can lead to severe myocardial infarction and lethal arrhythmia, as presented in this case.
Case Presentation: A 63-year-old man presented with typical prolonged chest pain, palpitations leading to near syncope, severe fatigue, loss of appetite, dizziness, and somnolence 2 days before admission. The patient exhibited somnolence, hypotension, thin eyebrows, and pretibial pitting edema. Electrocardiography revealed sinus rhythm with a prolonged QT interval, inferolateral-anterior ischemia, and a troponin-T value five times above the upper limit of normal. Therefore, the working diagnosis included non&#x2013;ST-elevation myocardial infarction Killip IV, severe biventricular heart failure, severe acute kidney injury, and severe acute liver injury. On the third day of treatment, the patient experienced two consecutive episodes of unstable ventricular tachycardia and one episode of return of spontaneous circulation cardiac arrest. Thyroid examination incidentally revealed severe hypothyroidism with severe hyperkalemia. After other causes were excluded, the diagnosis of myxedema crisis was assumed. Oral thyroid therapy, levothyroxine (100 &#xB5;g once daily), was administered. Within 3 days of initiating all treatments, the patient experienced significant hemodynamic improvement, improved kidney function, and normalization of liver function, accompanied by the disappearance of dyspnea, chest pain, and edema, with a compos mentis status. The patient was discharged with stable hemodynamics without support on the tenth day of treatment and underwent a coronary computed tomography angiography at an outpatient facility, which showed near-normal coronary results. The patient has been on routine follow-up for almost 1 year with levothyroxine (50 &#xB5;g once daily) and has recently demonstrated good left ventricular function (ejection fraction=50%) and good functional capacity on an exercise test.
Conclusion: Clinicians should consider hypothyroidism crisis in the differential diagnosis for myocardial infarction, heart failure, and lethal arrhythmia, and treatment should be initiated immediately.</abstract>
    <web_url>https://jthc.tums.ac.ir/index.php/jthc/article/view/2277</web_url>
    <pdf_url>https://jthc.tums.ac.ir/index.php/jthc/article/download/2277/1229</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>20</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2025</Year>
        <Month>12</Month>
        <Day>06</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Reduced Left Ventricular Global Longitudinal Strain in the Coronary Slow Flow Phenomenon: A Systematic Review and Meta-Analysis</title>
    <FirstPage>310</FirstPage>
    <LastPage>322</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Mahin</FirstName>
        <LastName>Seifi Alan</LastName>
        <affiliation locale="en_US">Alborz University of Medical Sciences</affiliation>
      </Author>
      <Author>
        <FirstName>Kobra</FirstName>
        <LastName>Hosseini</LastName>
        <affiliation locale="en_US">Alborz University of Medical Sciences</affiliation>
      </Author>
      <Author>
        <FirstName>Sanaz</FirstName>
        <LastName>Seifi Alan</LastName>
        <affiliation locale="en_US">Alborz University of Medical Sciences</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Mirzaei</LastName>
        <affiliation locale="en_US">Alborz University of Medical Sciences</affiliation>
      </Author>
      <Author>
        <FirstName>Peyman</FirstName>
        <LastName>Saeedi</LastName>
        <affiliation locale="en_US">Alborz University of Medical Sciences</affiliation>
      </Author>
      <Author>
        <FirstName>Soroush</FirstName>
        <LastName>Bahrami</LastName>
        <affiliation locale="en_US">Alborz University of Medical Sciences</affiliation>
      </Author>
      <Author>
        <FirstName>Vahid</FirstName>
        <LastName>Shahnavaz</LastName>
        <affiliation locale="en_US">Alborz University of Medical Sciences</affiliation>
      </Author>
      <Author>
        <FirstName>Haniyeh</FirstName>
        <LastName>Rashidi</LastName>
        <affiliation locale="en_US">Alborz University of Medical Sciences</affiliation>
      </Author>
      <Author>
        <FirstName>Mahnaz</FirstName>
        <LastName>Seifi Alan</LastName>
        <affiliation locale="en_US">Alborz University of Medical Sciences</affiliation>
      </Author>
      <Author>
        <FirstName>Hadith</FirstName>
        <LastName>Rastad</LastName>
        <affiliation locale="en_US">Alborz University of Medical Sciences</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>10</Month>
        <Day>03</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>11</Month>
        <Day>04</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: The coronary slow flow phenomenon (CSFP) involves delayed coronary artery filling without obstruction and is associated with angina and myocardial ischemia. This meta-analysis assessed the link between CSFP and impaired left ventricular global longitudinal strain (LVGLS), a marker of subclinical myocardial dysfunction.
Methods: A systematic search (PubMed, Embase, Scopus up to January 2025) identified 18 observational studies comparing LVGLS and layer-specific strain in patients with CSFP vs controls with normal coronary flow.
Results: Patients with CSFP showed significantly reduced LVGLS vs controls (SMD, 1.22; 95% CI, 0.69 to 1.75). Layer-specific analysis revealed impairment across all myocardial layers, most pronounced in the endocardium (SMD, 0.79; 95% CI, 0.21 to 1.38). While left ventricular ejection fraction (LVEF) was preserved, LVGLS demonstrated moderate-to-high diagnostic accuracy for CSFP (AUC, 0.80; 95% CI, 0.66 to 0.95). Reduced LVGLS independently predicted CSFP (adjusted OR, 1.43; 95% CI, 1.19 to 1.46). Exercise stress effects on LVGLS were inconsistent.
Conclusion: CSFP is associated with impaired LVGLS, particularly in the endocardial layer, despite preserved LVEF. LVGLS may serve as a noninvasive marker for subclinical dysfunction in CSFP.</abstract>
    <web_url>https://jthc.tums.ac.ir/index.php/jthc/article/view/2366</web_url>
    <pdf_url>https://jthc.tums.ac.ir/index.php/jthc/article/download/2366/1234</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>20</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2025</Year>
        <Month>12</Month>
        <Day>06</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Health Literacy and Treatment Adherence in Older Patients with Hypertension</title>
    <FirstPage>2393</FirstPage>
    <LastPage>2393</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Safoura</FirstName>
        <LastName>Dorri</LastName>
        <affiliation locale="en_US">Nursing and Midwifery Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>11</Month>
        <Day>16</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>11</Month>
        <Day>18</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">I read with great interest the recent article by Taskin Yilmaz et al (Vol. 20, No. 2, 2025) examining the association between health literacy and treatment adherence among older patients with hypertension.
The authors&#x2019; findings-particularly the significant relationship between both functional and communicative health literacy scores and improved blood pressure control-provide valuable evidence for refining patient-centered educational strategies.
I wish to highlight two practical points and offer one suggestion for future research. First, the authors reported that media exposure and active search for health information were linked to better blood pressure control. This observation suggests that community-based educational modules&#x2014;such as short instructional videos tailored for older adults and family-centered counseling sessions-could be implemented and evaluated as adjuncts to routine care. Second, given the cross-sectional design of the study, causal inference remains limited. Potential confounders such as cognitive status and social support may also influence both literacy and adherence. Incorporating brief cognitive screening tools (eg, Mini-Cog) and validated social support scales in future studies would help clarify whether health literacy acts as an independent mediating factor.
Finally, I recommend evaluating a structured low-literacy educational package delivered during hospitalization and reinforced through nurse-led telephone follow-up. This model is practical, scalable, and allows measurable outcomes in blood pressure control within 3 months, potentially improving quality of life while reducing the burden on health care systems.</abstract>
    <web_url>https://jthc.tums.ac.ir/index.php/jthc/article/view/2393</web_url>
    <pdf_url>https://jthc.tums.ac.ir/index.php/jthc/article/download/2393/1236</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>20</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2026</Year>
        <Month>01</Month>
        <Day>25</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Intracardiac Echocardiography in Contemporary Electro-Physiology: The Imaging Engine Behind the Fluoroless ERA</title>
    <FirstPage>255</FirstPage>
    <LastPage>258</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Hany</FirstName>
        <LastName>Demo</LastName>
        <affiliation locale="en_US">Swedish Hospital - Endeavour Health, Chicago, United States</affiliation>
      </Author>
      <Author>
        <FirstName>Mansour</FirstName>
        <LastName>Razminia</LastName>
        <affiliation locale="en_US">Saint Joseph Hospital, Chicago, United States.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>12</Month>
        <Day>23</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>12</Month>
        <Day>23</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Intracardiac echocardiography (ICE) has evolved from an adjunct procedure to a major imaging component of contemporary electrophysiology (EP) and is transforming the assessment of complex ablation and device cases.&#xA0;This growth corresponds to an inflection point for EP practice in response to converging pressures: an interest in improving safety and efficiency in EP procedures, an ever-increasing trend toward minimal or zero fluoroscopy procedures, and a commensurate development of catheter technology and image integration.&#xA0;ICE specifically meets all of these demands by providing high-resolution intracardiac images through conscious sedation techniques and decreasing ionizing radiation exposure.</abstract>
    <web_url>https://jthc.tums.ac.ir/index.php/jthc/article/view/2413</web_url>
    <pdf_url>https://jthc.tums.ac.ir/index.php/jthc/article/download/2413/1237</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>20</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2025</Year>
        <Month>12</Month>
        <Day>06</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Exploring the Impact of Fragmented QRS on Ejection Fraction and Other Echocardiographic Parameters in Systemic Sclerosis Patients: A Retrospective Cohort Study</title>
    <FirstPage>259</FirstPage>
    <LastPage>265</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Aida</FirstName>
        <LastName>Mohamadi</LastName>
        <affiliation locale="en_US">Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Tamartash</LastName>
        <affiliation locale="en_US">Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Sepehr</FirstName>
        <LastName>Nayebirad</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Farhad</FirstName>
        <LastName>Gharibdoost</LastName>
        <affiliation locale="en_US">Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Javady Nejad</LastName>
        <affiliation locale="en_US">Baharloo Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Maedeh</FirstName>
        <LastName>Majidi Shad</LastName>
        <affiliation locale="en_US">Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Motahare</FirstName>
        <LastName>Hatami</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hoda</FirstName>
        <LastName>Kavosi</LastName>
        <affiliation locale="en_US">Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>07</Month>
        <Day>21</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>09</Month>
        <Day>23</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Systemic sclerosis (SSc) is an autoimmune connective tissue disorder that leads to fibrosis of the skin and internal organs. Fragmented QRS (fQRS) is an important electrocardiographic (ECG) finding related to myocardial fibrosis. This study aimed to evaluate the effect of fQRS on ejection fraction (EF) and other echocardiographic parameters in individuals diagnosed with SSc.
Methods: This was a retrospective cohort study consisting of 52 patients with fQRS as the case group and 60 patients without fQRS as the control group. The characteristics and echocardiographic parameters of the patients from a minimum of a 3-year interval were recorded. All data were compared between the two groups using SPSS software, version 20.0 (IBM Corp).
Results: There were no significant differences in demographics, paraclinical results, and echocardiographic parameters, including average EF, pulmonary hypertension, and tricuspid regurgitation velocity, between cases and controls at the beginning and end of the follow-up.
Conclusion: Based on our results, fQRS had no significant effect on EF and other echocardiographic parameters over at least a 3-year interval in SSc patients. However, additional research with longer follow-up periods and larger sample sizes is needed to characterize the association fully.</abstract>
    <web_url>https://jthc.tums.ac.ir/index.php/jthc/article/view/2311</web_url>
    <pdf_url>https://jthc.tums.ac.ir/index.php/jthc/article/download/2311/1238</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>20</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2025</Year>
        <Month>12</Month>
        <Day>06</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Diabetes Modifies the Association Between Renal Function and Left Ventricular Ejection Fraction in Heart Failure Patients: A Cross-Sectional Study</title>
    <FirstPage>266</FirstPage>
    <LastPage>275</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Nuril</FirstName>
        <LastName>Abshori</LastName>
        <affiliation locale="en_US">Medical Doctor Program Faculty of Medicine and Health Sciences, Maulana Malik Ibrahim Islamic State University Malang, Malang, Indonesia</affiliation>
      </Author>
      <Author>
        <FirstName>Muhammad</FirstName>
        <LastName>Iqhrammullah</LastName>
        <affiliation locale="en_US">Universitas Muhammadiyah Aceh</affiliation>
      </Author>
      <Author>
        <FirstName>Syanindita</FirstName>
        <LastName>Wardhani</LastName>
        <affiliation locale="en_US">Master of Biomedical Science, Faculty of Medicine, Universitas Brawijaya</affiliation>
      </Author>
      <Author>
        <FirstName>Tio</FirstName>
        <LastName>Fauzi</LastName>
        <affiliation locale="en_US">Faculty of Medicine and Health Sciences, Maulana Malik Ibrahim Islamic State University, Malang, Indonesia</affiliation>
      </Author>
      <Author>
        <FirstName>Khoirunnisa</FirstName>
        <LastName>Andarwati</LastName>
        <affiliation locale="en_US">Faculty of Medicine and Health Sciences, Maulana Malik Ibrahim Islamic State University, Malang, Indonesia</affiliation>
      </Author>
      <Author>
        <FirstName>Aldivo</FirstName>
        <LastName>Pradana</LastName>
        <affiliation locale="en_US">Medical Doctor Program, Faculty of Medicine, Brawijaya University, Malang, Indonesia</affiliation>
      </Author>
      <Author>
        <FirstName>Achmad</FirstName>
        <LastName>Arif</LastName>
        <affiliation locale="en_US">Department of Internal Medicine, Faculty of Medicine and Health Sciences, Maulana Malik Ibrahim Islamic State University Malang, Indonesia</affiliation>
      </Author>
      <Author>
        <FirstName>Iwal Reza</FirstName>
        <LastName>Ahdi</LastName>
        <affiliation locale="en_US">Department of Internal Medicine, Faculty of Medicine and Health Sciences, Maulana Malik Ibrahim Islamic State University Malang, Indonesia</affiliation>
      </Author>
      <Author>
        <FirstName>Djanggan</FirstName>
        <LastName>Sargowo</LastName>
        <affiliation locale="en_US">Department of Cardiology, Faculty of Medicine, Brawijaya University, Malang, Indonesia</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>08</Month>
        <Day>13</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>10</Month>
        <Day>21</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Heart failure (HF) and chronic kidney disease (CKD) frequently coexist and contribute to poor clinical outcomes, particularly in patients with diabetes mellitus. The modifying effect of diabetes on the association between renal markers and left ventricular ejection fraction (LVEF) remains poorly understood.
Objective: We sought to investigate whether diabetes modifies the relationship between renal biomarkers and LVEF in hospitalized patients with HF.
Methods: We conducted a cross-sectional analysis involving 112 patients diagnosed with HF who were admitted to a tertiary care hospital. Data were extracted from electronic medical records, including demographic characteristics, comorbidities, laboratory values, and echocardiographic assessments. The primary outcome was LVEF, as determined by transthoracic echocardiography. Renal function was evaluated using serum urea, creatinine, hemoglobin, and the estimated glomerular filtration rate (eGFR). To examine whether the association between these renal markers and LVEF differed based on diabetes status, we fitted multivariable linear regression models including interaction terms between diabetes and each renal marker. All models were adjusted for age, sex, and HF subtype (HFpEF, HFmrEF, or HFrEF).
Results: In multivariable models, both urea and creatinine remained significantly associated with LVEF (P=0.007 and P=0.005, respectively). Hemoglobin and eGFR did not show significant main effects in both unadjusted and adjusted models. In the moderation analysis, a significant interaction was found between diabetes and urea (P=0.022). Among patients with diabetes, an increase in urea was associated with a significant reduction in LVEF (P=0.022), whereas the association was attenuated in patients without diabetes. Similarly, the interaction between creatinine and diabetes was significant (&#x3B2;=&#x2212;13.12; P=0.003). In contrast, the interaction between diabetes and eGFR approached significance (&#x3B2;=0.11; P=0.076). No significant interaction was found for hemoglobin and diabetes (&#x3B2;=&#x2212;0.70; P=0.67).
Conclusion: Diabetes modifies the relationship between renal function and systolic performance in patients with HF. The striation locale="en_US">Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Elnaz</FirstName>
        <LastName>Javanshir</LastName>
        <affiliation locale="en_US">Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2021</Year>
        <Month>12</Month>
        <Day>27</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>02</Month>
        <Day>03</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Atrial fibrillation (AF) is a supraventricular tachyarrhythmia characterized by disorganized atrial activity and subsequent mechanical atrial failure. Postoperative AF is a frequent complication of coronary artery bypass grafting (CABG). Although there is evidence of decreased AF after CABG with statin usage, information is scarce regarding a direct comparison between atorvastatin and rosuvastatin. The present study was conducted to compare the efficacy of rosuvastatin and atorvastatin in preventing post-CABG AF.
Methods: The present double-blind randomized comparative clinical trial selected CABG candidates with stable ischemic heart disease or acute coronary syndromes. Atorvastatin (40 mg per day) or rosuvastatin (20 mg per day) was prescribed 1 week before surgery, and the outcomes were compared.
Results: Two-hundred patients, 100 cases in each group, completed the study. Twenty-five patients in each group were female, and the mean age was 59.30&#xB1;8.42 years in the rosuvastatin group and 60.13&#xB1;9.40 years in the atorvastatin group (P=0.513). The frequency of AF was 31% in the atorvastatin group and 27% in the rosuvastatin group (P=0.534). No significant differences existed between the groups concerning the length of hospital and ICU stay (P=0.333 and P=0.161) and in-hospital and 3-month mortality (P=0.315 and P=0.648). A subgroup analysis of only patients with stable ischemic heart disease could not detect a significant difference between the study groups in any of the investigated outcomes. Our logistic regression analysis showed an association only between age and the incidence of AF after CABG (OR, 1.12; 95% CI, 1.05 to 1.20; P&lt;0.01).
Conclusion: Rosuvastatin and atorvastatin are similar concerning the prevention of post-CABG AF, but there is a need for future well-designed multicenter studies on this topic.&#xA0;</abstract>
    <web_url>https://jthc.tums.ac.ir/index.php/jthc/article/view/1584</web_url>
    <pdf_url>https://jthc.tums.ac.ir/index.php/jthc/article/download/1584/1064</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>18</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2023</Year>
        <Month>04</Month>
        <Day>30</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Correlations between Cardiovascular Risk Factors and Ventricular Arrhythmias Following Primary Percutaneous Coronary Intervention in Patients with ST-Elevation Myocardial Infarction</title>
    <FirstPage>122</FirstPage>
    <LastPage>128</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Hamid</FirstName>
        <LastName>Khederlou</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Seyede Vanoushe</FirstName>
        <LastName>Azimi Pirsaraei</LastName>
        <affiliation locale="en_US">Student Research Committee, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Elaheh</FirstName>
        <LastName>Rabbani</LastName>
        <affiliation locale="en_US">Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Morteza</FirstName>
        <LastName>Motedayen</LastName>
        <affiliation locale="en_US">Cardiology Department, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>01</Month>
        <Day>15</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>06</Month>
        <Day>28</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Ventricular arrhythmias (VAs), which result from acute myocardial infarction and revascularization, are preventable causes of sudden cardiac death. This study aimed to determine the incidence, types, and risk factors of VAs in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention (PCI).
Methods: This cross-sectional study was conducted at the cardiology department of a tertiary care cardiac center in Zanjan, Iran. All the patients were monitored during hospitalization, and the incidence of cardiac arrhythmias and the outcomes were recorded.
Result: Among 315 patients, the mean age was 62.14&#xB1;10.11 years, and 76.2% were male. Male gender was significantly associated with VA occurrence (P=0.038). Among the patients, 50.5% had VAs, of which 26.4% were sustained ventricular tachycardia (sustained VT) and ventricular fibrillation (VF). Sustained VT and VF, but not total arrhythmias, were more common in anterior infarctions. Most arrhythmias occurred during the first 12 hours, and frequent premature ventricular contractions (43.3%) and idioventricular rhythm (20.1%) were the most common. A history of PCI and coronary artery bypass grafting (CABG) was associated with substantially reduced arrhythmias (P=0.017 and P=0.013, respectively). However, cardiovascular risk factors exerted no statistically significant effects on the VA type.
Conclusion: Approximately half of our patients experienced reperfusion-induced VAs. Overall, gender and a history of PCI and CABG were significantly associated with VA occurrence. Therefore, males and patients without a positive history of PCI and CABG should receive antiarrhythmic drugs as a precaution.</abstract>
    <web_url>https://jthc.tums.ac.ir/index.php/jthc/article/view/1795</web_url>
    <pdf_url>https://jthc.tums.ac.ir/index.php/jthc/article/download/1795/1071</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>18</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2023</Year>
        <Month>04</Month>
        <Day>30</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Association between Cardiovascular Risk Factors and High-risk Features in Myocardial Perfusion Imaging: A Multicenter Study</title>
    <FirstPage>129</FirstPage>
    <LastPage>135</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Hamid</FirstName>
        <LastName>Khederlou</LastName>
        <affiliation locale="en_US">Tehran University of Medical Sciences</affiliation>
      </Author>
      <Author>
        <FirstName>Amirali</FirstName>
        <LastName>Mohammadi</LastName>
        <affiliation locale="en_US">Zanjan university of Medical sciences</affiliation>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Tajik</LastName>
        <affiliation locale="en_US">Tehran University of Medical Sciences</affiliation>
      </Author>
      <Author>
        <FirstName>Mohamad</FirstName>
        <LastName>Kazemshiroodi</LastName>
        <affiliation locale="en_US">Iran University of Medical Sciences</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>05</Month>
        <Day>06</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>06</Month>
        <Day>28</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Myocardial perfusion imaging (MPI) is a noninvasive method with acceptable sensitivity and specificity in diagnosing coronary artery disease (CAD) in moderate-risk patients, including those with CAD risk factors.
Methods: The present cross-sectional, prospective study was conducted on 4886 patients from April 2020 through March 2023 at Chamran and Tehran Heart Center hospitals. A questionnaire regarding anthropometric variables, demographic characteristics, CAD risk factors, and MPI findings was designed.
Results: Totally, 2179 patients (44.6%) had abnormal MPI. Patients with abnormal MPI were significantly older than those with normal MPI. Older age (OR, 1.64; 95% CI, 1.2 to 1.72; P&lt;0.001), diabetes mellitus (DM) (OR, 1.36; 95% CI, 1.1 to 1.48; P=0.012), hypertension (OR, 1.24; 95% CI, 1.04 to 1.37; P=0.032), and dyslipidemia (OR, 1.54; 95% CI, 1.25 to 1.8; P&lt;0.001) were associated with abnormal MPI independently. Patients with more CAD risk factors were more likely to have abnormal MPI. Thus, in patients without or at most with 1 risk factor and those with 8 CAD risk factors, the likelihood of abnormal MPI was 3.7% and 76.2%, respectively. The frequency of left ventricular dilation and right ventricular prominence was significantly higher in patients with older age (P&lt;0.001 and P=0.043, respectively), dyslipidemia (P&lt;0.001 and P=0.007, respectively), DM (P&lt;0.001 and P&lt;0.001, respectively), and hypertension (P=0.048 and P=0.057, respectively).
Conclusion: Individuals with CAD risk factors, especially those with older age, DM, hypertension, or dyslipidemia, require meticulous attention during CAD evaluation, particularly via MPI.</abstract>
    <web_url>https://jthc.tums.ac.ir/index.php/jthc/article/view/1854</web_url>
    <pdf_url>https://jthc.tums.ac.ir/index.php/jthc/article/download/1854/1066</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>18</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2023</Year>
        <Month>04</Month>
        <Day>30</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">The Impact of the COVID-19 Pandemic on Hospitalization Rates due to Prosthetic Valve Thrombosis</title>
    <FirstPage>136</FirstPage>
    <LastPage>141</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Mana</FirstName>
        <LastName>Jameie</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Cardiovascular Disease Research Institute</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Safarian Nematabad</LastName>
        <affiliation locale="en_US">Ali IbnAbitaleb Educational and Treatment Hospital, Rafsanjan University of Medical Sciences, Rafsanjan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Pejman</FirstName>
        <LastName>Mansouri</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Cardiovascular Disease Research Institute</affiliation>
      </Author>
      <Author>
        <FirstName>Arash</FirstName>
        <LastName>Jalali</LastName>
        <affiliation locale="en_US">&#x201C;The Journal of Tehran University Heart Center&#x201D;</affiliation>
      </Author>
      <Author>
        <FirstName>Faezeh</FirstName>
        <LastName>Aghajai</LastName>
        <affiliation locale="en_US">Research development Center, Arash women's Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Masoumeh</FirstName>
        <LastName>Lotfi-Tokaldany</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Cardiovascular Disease Research Institute</affiliation>
      </Author>
      <Author>
        <FirstName>Hassan</FirstName>
        <LastName>Aghajani</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Cardiovascular Disease Research Institute</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2022</Year>
        <Month>12</Month>
        <Day>06</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>04</Month>
        <Day>18</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Backgrounds: Studies have shown a decline in the admission rates of various diseases during the COVID-19 pandemic. Prosthetic valve thrombosis (PVT) is a rare condition followed by surgical or transcatheter valvular interventions. Considering the lack of data on hospitalization rates due to PVT during the pandemic, this study evaluated the implications of the COVID-19 pandemic on PVT admissions and characteristics in a tertiary referral center.
Methods: Data from all the consecutive patients hospitalized due to PVT between February 2020 and February 2021 (the first year of the pandemic) were collected from medical records and compared clinically with the corresponding time before the pandemic (February 2019 through February 2020). Variables of interest included the number of hospitalization, patient and valve characteristics, diagnostic and management strategies, and in-hospital events.
Results: Forty patients (32.5% male, age: 54.0 [46.5-62.0 y] comprised the study population. We observed a considerable decline in hospitalization rates during the pandemic, from 31 to 9 patients. Admitted patients were 8 years younger, had a higher proportion of the New York Heart Association functional class III or IV symptoms (44.4% vs 22.6%), were more often treated with fibrinolysis (33.3% vs 22.6%) or surgical approaches (33.3% vs 22.6%), and were discharged 6 days sooner.
Conclusion: We described a reduction in PVT hospitalization. Patients presented with a higher proportion of severe dyspnea and had increased treatment with fibrinolysis/surgical approaches. These observations highlight the necessity of the active surveillance of patients with prosthetic valves by caregivers for timely diagnosis and appropriate management during the pandemic.</abstract>
    <web_url>https://jthc.tums.ac.ir/index.php/jthc/article/view/1768</web_url>
    <pdf_url>https://jthc.tums.ac.ir/index.php/jthc/article/download/1768/1067</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>18</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2023</Year>
        <Month>04</Month>
        <Day>30</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Giant Sinoatrial Nodal Artery Aneurysm with Fistula into the Right Atrium Treated by Partial Resection and Plication: A Case Report</title>
    <FirstPage>142</FirstPage>
    <LastPage>145</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Usha</FirstName>
        <LastName>Kumari</LastName>
        <affiliation locale="en_US">Dow University of Health Sciences, Karachi, Pakistan.</affiliation>
      </Author>
      <Author>
        <FirstName>Mansoor</FirstName>
        <LastName>Rahman</LastName>
        <affiliation locale="en_US">Postgraduate Trainee Cardiology, Lady Reading Hospital, Peshawar.</affiliation>
      </Author>
      <Author>
        <FirstName>Muneeb Ullah</FirstName>
        <LastName>Jan</LastName>
        <affiliation locale="en_US">Department of Cardiology, Lady Reading Hospital, Peshawar Pakistan</affiliation>
      </Author>
      <Author>
        <FirstName>Salecah Rahmat&#xA0;</FirstName>
        <LastName>Ullah</LastName>
        <affiliation locale="en_US">1. Central Michigan University Hospital Saginaw, USA. 2. Khawaja Safdar Medical College Sialkot, Pakistan</affiliation>
      </Author>
      <Author>
        <FirstName>Fakhar</FirstName>
        <LastName>Abbas</LastName>
        <affiliation locale="en_US">King Edward Medical University, Lahore, Pakistan.</affiliation>
      </Author>
      <Author>
        <FirstName>Zara</FirstName>
        <LastName>Mirza</LastName>
        <affiliation locale="en_US">Senior Resident, Cardiac Surgery, National Institute of Cardiovascular Disorders, Pakistan.</affiliation>
      </Author>
      <Author>
        <FirstName>Salim</FirstName>
        <LastName>Surani</LastName>
        <affi